James WIllcocks
Founder bei OXFORD NANOPORE TECHNOLOGIES PLC
Vermögen: 7 Mio $ am 31.03.2024
Profil
James WIllcocks is the founder of Oxford Nanopore Technologies Plc, where he holds the title of Director & Chief Strategy Officer.
He founded the company in 2005.
He is currently a Director at Veiovia Ltd.
Dr. WIllcocks has also held positions as a Director at IP Group Plc and as Director-Business Development at Oxford NanoLabs Ltd.
He has a graduate degree and a doctorate from the University of Oxford.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2022 | 4 729 700 ( 0,55% ) | 7 Mio $ | 31.03.2024 |
Aktive Positionen von James WIllcocks
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Founder | 01.01.2005 |
| Veiovia Ltd. | Director/Board Member | - |
Ehemalige bekannte Positionen von James WIllcocks
| Unternehmen | Position | Ende |
|---|---|---|
Oxford NanoLabs Ltd.
 Oxford NanoLabs Ltd. Medical SpecialtiesHealth Technology Oxford NanoLabs Ltd. develops nanopore technology to power a revolution in DNA analysis. It develops products for applications in genomics, pharmacogenomics and high thoroughput drug discovery as well as for the home defence and security sectors. The company was founded by Hagan Bayley in 2005 and is headquartered in Kidlington, UK. | Corporate Officer/Principal | 15.01.2009 |
| IP GROUP PLC | Director/Board Member | - |
Ausbildung von James WIllcocks
| University of Oxford | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
| IP GROUP PLC | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Oxford NanoLabs Ltd.
Oxford NanoLabs Ltd. Medical SpecialtiesHealth Technology Oxford NanoLabs Ltd. develops nanopore technology to power a revolution in DNA analysis. It develops products for applications in genomics, pharmacogenomics and high thoroughput drug discovery as well as for the home defence and security sectors. The company was founded by Hagan Bayley in 2005 and is headquartered in Kidlington, UK. | Health Technology |
| Veiovia Ltd. |
